Post by Michel Pompeu Sá

🔥Hot off the press🔥 #AATS2026 Read our simultaneous publication in JAHA — Journal of the American Heart Association about #ViV-#TMVR versus #RedoSMVR in patients with failed bioprosthetic #MitralValve 🔗Open access to full-text article here: https://lnkd.in/dqtHAvvR 💥Take-home message: In patients amenable to ViV‐TMVR, this procedure shows a lower initial risk of death and complications, but higher mortality after 6 months in comparison with redo‐SMVR. These findings highlight the importance of striking a balance between upfront surgical risk and estimated life expectancy when selecting interventions. 💥Nice collaboration with Jose Luis Navia Antonio Polanco, MD Nicolas Brozzi Federico Napoli Xander J. Leo Consoli Thiago Camarotti Gabriel Neves Leonardo Dexheimer da Silva Asad Iqbal CME Cleveland Clinic Florida Cleveland Clinic Florida Cleveland Clinic Lerner College of Medicine Cleveland Clinic Education Cleveland Clinic Lars Svensson Marc Gillinov Eric E. Roselli David Baran Ali Hage Gilbert Tang, MD, MSc, MBA Kendra J. Grubb, MD, MHA, MSc, FACC Isaac George M.D., FACC, FACS Tsuyoshi Kaneko Arnar Geirsson Marc Pelletier MD Gorav Ailawadi, MD, MBA Torsten Doenst Michael Borger Mateo Marin-Cuartas Tom C. Nguyen Prof. Dr. med. Alexander Weymann, FECTS, FESC, MHBA Gilles Dreyfus Scott Goldman Panos N. Vardas Rob Gallegos Bruce Ovbiagele, MD, MSc, MAS, MBA, MLS Michael Walter Cardiovascular Business